DexCom (LTS:0A4M) Inventories, Raw Materials & Components: $248 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0A4M DexCom Inc LTS:0A4M
91 GF Score
Price $72.96
GF Value $99.66
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Inventories, Raw Materials & Components?

DexCom LTS:0A4M 91 Inventories, Raw Materials & Components is $248 Mil as of Mar. 2026. GuruFocus rates LTS:0A4M with a GF Score™ of 91/100 and a GF Value™ of $99.66 (Modestly Undervalued). The stock has 3 warning signs investors should review.

DexCom's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $248 Mil.

DexCom's quarterly raw materials declined from Sep. 2025 ($266 Mil) to Dec. 2025 ($258 Mil) and declined from Dec. 2025 ($258 Mil) to Mar. 2026 ($248 Mil).

DexCom's annual raw materials increased from Dec. 2023 ($320 Mil) to Dec. 2024 ($327 Mil) but then declined from Dec. 2024 ($327 Mil) to Dec. 2025 ($258 Mil).

DexCom Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for DexCom's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom Inventories, Raw Materials & Components Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145.20 159.00 319.50 327.10 257.60

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 366.00 346.10 266.00 257.60 247.90
LTS:0A4M
91GF Score
DexCom Inc LTS:0A4M
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $248 Mil mean?
DexCom (LTS:0A4M) has a Inventories, Raw Materials & Components of $248 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on DexCom and its competitors.
Is DexCom's Inventories, Raw Materials & Components too high?
DexCom's current Inventories, Raw Materials & Components is $248 Mil. Overall, DexCom has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Inventories, Raw Materials & Components compare to GEHC and STE?
DexCom's Inventories, Raw Materials & Components of $248 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on DexCom and its competitors. DexCom's current Inventories, Raw Materials & Components is $248 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (LTS:0A4M) is currently considered Modestly Undervalued. The stock's GF Value™ is $99.66, compared to a current price of $72.96 — trading 26.8% below its estimated fair value. The current Inventories, Raw Materials & Components is $248 Mil. DexCom's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For DexCom (LTS:0A4M), the current Inventories, Raw Materials & Components is $248 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (LTS:0A4M) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of $72.96 is trading 26.8% below its estimated GF Value™ of $99.66. GuruFocus considers DexCom to be Modestly Undervalued.

Key valuation signals for LTS:0A4M:

  • Inventories, Raw Materials & Components: $248 Mil
  • GF Value™: $99.66 vs. price of $72.96 (26.8% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the LTS:0A4M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
91GF Score

Get the complete analysis for LTS:0A4M

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.96
Price
$99.66
GF Value